Biogenesis of influenza a virus hemagglutinin cross-protective stem epitopes.

Antigenic variation in the globular domain of influenza A virus (IAV) hemagglutinin (HA) precludes effective immunity to this major human pathogen. Although the HA stem is highly conserved between influenza virus strains, HA stem-reactive antibodies (StRAbs) were long considered biologically inert....

Full description

Bibliographic Details
Main Authors: Javier G Magadán, Meghan O Altman, William L Ince, Heather D Hickman, James Stevens, Aaron Chevalier, David Baker, Patrick C Wilson, Rafi Ahmed, Jack R Bennink, Jonathan W Yewdell
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-06-01
Series:PLoS Pathogens
Online Access:http://europepmc.org/articles/PMC4055778?pdf=render
id doaj-74024ffa48a944a1a6108bc9315387d3
record_format Article
spelling doaj-74024ffa48a944a1a6108bc9315387d32020-11-25T02:20:16ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742014-06-01106e100420410.1371/journal.ppat.1004204Biogenesis of influenza a virus hemagglutinin cross-protective stem epitopes.Javier G MagadánMeghan O AltmanWilliam L InceHeather D HickmanJames StevensAaron ChevalierDavid BakerPatrick C WilsonRafi AhmedJack R BenninkJonathan W YewdellAntigenic variation in the globular domain of influenza A virus (IAV) hemagglutinin (HA) precludes effective immunity to this major human pathogen. Although the HA stem is highly conserved between influenza virus strains, HA stem-reactive antibodies (StRAbs) were long considered biologically inert. It is now clear, however, that StRAbs reduce viral replication in animal models and protect against pathogenicity and death, supporting the potential of HA stem-based immunogens as drift-resistant vaccines. Optimally designing StRAb-inducing immunogens and understanding StRAb effector functions require thorough comprehension of HA stem structure and antigenicity. Here, we study the biogenesis of HA stem epitopes recognized in cells infected with various drifted IAV H1N1 strains using mouse and human StRAbs. Using a novel immunofluorescence (IF)-based assay, we find that human StRAbs bind monomeric HA in the endoplasmic reticulum (ER) and trimerized HA in the Golgi complex (GC) with similar high avidity, potentially good news for producing effective monomeric HA stem immunogens. Though HA stem epitopes are nestled among several N-linked oligosaccharides, glycosylation is not required for full antigenicity. Rather, as N-linked glycans increase in size during intracellular transport of HA through the GC, StRAb binding becomes temperature-sensitive, binding poorly to HA at 4°C and well at 37°C. A de novo designed, 65-residue protein binds the mature HA stem independently of temperature, consistent with a lack of N-linked oligosaccharide steric hindrance due to its small size. Likewise, StRAbs bind recombinant HA carrying simple N-linked glycans in a temperature-independent manner. Chemical cross-linking experiments show that N-linked oligosaccharides likely influence StRAb binding by direct local effects rather than by globally modifying the conformational flexibility of HA. Our findings indicate that StRAb binding to HA is precarious, raising the possibility that sufficient immune pressure on the HA stem region could select for viral escape mutants with increased steric hindrance from N-linked glycans.http://europepmc.org/articles/PMC4055778?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Javier G Magadán
Meghan O Altman
William L Ince
Heather D Hickman
James Stevens
Aaron Chevalier
David Baker
Patrick C Wilson
Rafi Ahmed
Jack R Bennink
Jonathan W Yewdell
spellingShingle Javier G Magadán
Meghan O Altman
William L Ince
Heather D Hickman
James Stevens
Aaron Chevalier
David Baker
Patrick C Wilson
Rafi Ahmed
Jack R Bennink
Jonathan W Yewdell
Biogenesis of influenza a virus hemagglutinin cross-protective stem epitopes.
PLoS Pathogens
author_facet Javier G Magadán
Meghan O Altman
William L Ince
Heather D Hickman
James Stevens
Aaron Chevalier
David Baker
Patrick C Wilson
Rafi Ahmed
Jack R Bennink
Jonathan W Yewdell
author_sort Javier G Magadán
title Biogenesis of influenza a virus hemagglutinin cross-protective stem epitopes.
title_short Biogenesis of influenza a virus hemagglutinin cross-protective stem epitopes.
title_full Biogenesis of influenza a virus hemagglutinin cross-protective stem epitopes.
title_fullStr Biogenesis of influenza a virus hemagglutinin cross-protective stem epitopes.
title_full_unstemmed Biogenesis of influenza a virus hemagglutinin cross-protective stem epitopes.
title_sort biogenesis of influenza a virus hemagglutinin cross-protective stem epitopes.
publisher Public Library of Science (PLoS)
series PLoS Pathogens
issn 1553-7366
1553-7374
publishDate 2014-06-01
description Antigenic variation in the globular domain of influenza A virus (IAV) hemagglutinin (HA) precludes effective immunity to this major human pathogen. Although the HA stem is highly conserved between influenza virus strains, HA stem-reactive antibodies (StRAbs) were long considered biologically inert. It is now clear, however, that StRAbs reduce viral replication in animal models and protect against pathogenicity and death, supporting the potential of HA stem-based immunogens as drift-resistant vaccines. Optimally designing StRAb-inducing immunogens and understanding StRAb effector functions require thorough comprehension of HA stem structure and antigenicity. Here, we study the biogenesis of HA stem epitopes recognized in cells infected with various drifted IAV H1N1 strains using mouse and human StRAbs. Using a novel immunofluorescence (IF)-based assay, we find that human StRAbs bind monomeric HA in the endoplasmic reticulum (ER) and trimerized HA in the Golgi complex (GC) with similar high avidity, potentially good news for producing effective monomeric HA stem immunogens. Though HA stem epitopes are nestled among several N-linked oligosaccharides, glycosylation is not required for full antigenicity. Rather, as N-linked glycans increase in size during intracellular transport of HA through the GC, StRAb binding becomes temperature-sensitive, binding poorly to HA at 4°C and well at 37°C. A de novo designed, 65-residue protein binds the mature HA stem independently of temperature, consistent with a lack of N-linked oligosaccharide steric hindrance due to its small size. Likewise, StRAbs bind recombinant HA carrying simple N-linked glycans in a temperature-independent manner. Chemical cross-linking experiments show that N-linked oligosaccharides likely influence StRAb binding by direct local effects rather than by globally modifying the conformational flexibility of HA. Our findings indicate that StRAb binding to HA is precarious, raising the possibility that sufficient immune pressure on the HA stem region could select for viral escape mutants with increased steric hindrance from N-linked glycans.
url http://europepmc.org/articles/PMC4055778?pdf=render
work_keys_str_mv AT javiergmagadan biogenesisofinfluenzaavirushemagglutinincrossprotectivestemepitopes
AT meghanoaltman biogenesisofinfluenzaavirushemagglutinincrossprotectivestemepitopes
AT williamlince biogenesisofinfluenzaavirushemagglutinincrossprotectivestemepitopes
AT heatherdhickman biogenesisofinfluenzaavirushemagglutinincrossprotectivestemepitopes
AT jamesstevens biogenesisofinfluenzaavirushemagglutinincrossprotectivestemepitopes
AT aaronchevalier biogenesisofinfluenzaavirushemagglutinincrossprotectivestemepitopes
AT davidbaker biogenesisofinfluenzaavirushemagglutinincrossprotectivestemepitopes
AT patrickcwilson biogenesisofinfluenzaavirushemagglutinincrossprotectivestemepitopes
AT rafiahmed biogenesisofinfluenzaavirushemagglutinincrossprotectivestemepitopes
AT jackrbennink biogenesisofinfluenzaavirushemagglutinincrossprotectivestemepitopes
AT jonathanwyewdell biogenesisofinfluenzaavirushemagglutinincrossprotectivestemepitopes
_version_ 1724872482364588032